Varaico: Literature-Extracted Genetic Variants

Gene:GLUD2
Variant:p.S498A
Back to variants list

GLUD2

NM_012084.4:p.S498A

Associated Papers

Generation of the ICGi019-B-1 and ICGi019-B-2 lines via correction of the p.Met659Ile (c.1977G>A) variant in MYH7 of patient-specific induced pluripotent stem cells using CRISPR/Cas9.

Shulgina AE et al.

Vavilovskii Zhurnal Genetiki I Selektsii, 2025

Neanderthal and Denisovan Glutamate Dehydrogenase 2 Evolution and Clinical Significance.

Aleshina YA et al.

International Journal of Molecular Sciences, 2025

Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.

Kuras M et al.

Cancers, 2025

40075679 (PubMed )
Supplement: cancers-17-00832-s001.zip › Table_S5._SAAVs.xlsx › Table_S5A

A Robust and Comprehensive Study of the Molecular and Genetic Basis of Neurodevelopmental Delay in a Sample of 3244 Patients, Evaluated by Exome Analysis in a Latin Population.

Lamilla J et al.

Diagnostics (basel, Switzerland), 2025

39941308 (PubMed )
Supplement: diagnostics-15-00376-s001.zip › diagnostics-3372801-supplementary.xlsx › Hoja1

The role of glutamate dehydrogenase in the ageing brain.

Zhou T et al.

Frontiers in Pharmacology, 2025

Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma.

Villa M et al.

British Journal of Cancer, 2024

39478125 (PubMed )
Supplement: 41416_2024_2881_MOESM1_ESM.pdf

Analysis of rare Parkinson's disease variants in millions of people.

Pitz V et al.

Npj Parkinson's Disease, 2024

Exploring the interplay between metabolomics and genetics in Parkinson's disease: Insights from ongoing research and future avenues.

Santos-Rebouças CB et al.

Mechanisms of Ageing and Development, 2023

Glutamate dehydrogenase: Potential therapeutic targets for neurodegenerative disease.

Pan C et al.

European Journal of Pharmacology, 2023

Analysis of rare Parkinson's disease variants in millions of people.

Pitz V et al.

Research Square, 2023

Study of Alzheimer's disease- and frontotemporal dementia-associated genes in the Cretan Aging Cohort.

Mathioudakis L et al.

Neurobiology of Aging, 2023

Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer.

Waks AG et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2022

35101884 (PubMed )
Supplement: ccr-21-2572_supplementary_table_s6_supps6.xls › Sheet1

Identification of candidate genes in a family with cancer overload by whole-exome sequencing.

Ödemiş DA et al.

The Turkish Journal of Pediatrics, 2022

Exome-Wide Search for Genes Associated With Central Nervous System Inflammatory Demyelinating Diseases Following CHIKV Infection: The Tip of the Iceberg.

Alves-Leon SV et al.

Frontiers in Genetics, 2021

Functional validation of a human GLUD2 variant in a murine model of Parkinson's disease.

Zhang W et al.

Cell Death & Disease, 2020

PARP1 V762A polymorphism affects the prognosis of myelodysplastic syndromes.

Gotoh N et al.

European Journal of Haematology, 2020

Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging.

Hou YC et al.

Proceedings of the National Academy of Sciences of the United States of America, 2020

31980526 (PubMed )
Supplement: pnas.1909378117.sapp.pdf

Reinterpretation of common pathogenic variants in ClinVar revealed a high proportion of downgrades.

Xiang J et al.

Scientific Reports, 2020

31942019 (PubMed )
Supplement: 41598_2019_57335_MOESM1_ESM.xlsx › Sup_table_1

Localization of Human Glutamate Dehydrogenases Provides Insights into Their Metabolic Role and Their Involvement in Disease Processes.

Mathioudakis L et al.

Neurochemical Research, 2019

Multiple Forms of Glutamate Dehydrogenase in Animals: Structural Determinants and Physiological Implications.

Bunik V et al.

Biology, 2016

XomAnnotate: Analysis of Heterogeneous and Complex Exome- A Step towards Translational Medicine.

Talukder AK et al.

Plos One, 2015

25905921 (PubMed )
Supplement: pone.0123569.s008.xls › BC9_ERR166333

The discovery of human of GLUD2 glutamate dehydrogenase and its implications for cell function in health and disease.

Shashidharan P et al.

Neurochemical Research, 2014

Deregulation of glutamate dehydrogenase in human neurologic disorders.

Plaitakis A et al.

Journal of Neuroscience Research, 2013

The human GLUD2 glutamate dehydrogenase and its regulation in health and disease.

Plaitakis A et al.

Neurochemistry International, 2011

Estrogen modification of human glutamate dehydrogenases is linked to enzyme activation state.

Borompokas N et al.

The Journal of Biological Chemistry, 2010

Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset.

Plaitakis A et al.

European Journal of Human Genetics : Ejhg, 2010

The human GLUD2 glutamate dehydrogenase: localization and functional aspects.

Zaganas I et al.

Neurochemistry International, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."